Sanofi handed payers nearly $12B in drug rebates last year

French drugmaker Sanofi handed insurers and pharmacy benefit managers rebates totaling more than half of its gross sales in the U.S. last year, resulting in net price declines across its portfolio despite list price hikes taken on dozens of its prescription products.